Bringing advanced cardiac ultrasound capabilities to more healthcare settings, UltraSight has raised $24.0M.
The company's AI-driven software provides real-time guidance and quality assessment, allowing medical professionals to consistently perform high-quality cardiac ultrasounds at the point of care, from clinics to remote areas, regardless of their sonography proficiency. UltraSight's solution has already secured FDA 510(k) Clearance, UKCA, CE Marked, and Israeli AMAR Clearance, underscoring its readiness for broader adoption.
